Can prostate cancer be predicted in BPH patients with elevated serum PSA and negative initial sextant biopsy? a multivariate analysis study
African Journal of Urology. 2003; 9 (1): 28-35
en Inglés
| IMEMR
| ID: emr-205540
ABSTRACT
Objective:
To define a predictor of prostate cancer in BPH patients with an intermediate PSA [4.1-10 ng/ml] and a negative initial sextant biopsy
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Inglés
Revista:
African J. Urol.
Año:
2003
Similares
MEDLINE
...
LILACS
LIS